image
RAPT Therapeutics, Inc. RAPT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.105
-13.7 %
$ 38.6 M
Market Cap
-0.35
P/E
BALANCE SHEET
173 M ASSETS
-34.89%
Growth Rates
1Year -34.89%
3Years 13.37%
5Years 20.02%
7Years 0.00%
10Years 0.00%
26.3 M LIABILITIES
24.95%
Growth Rates
1Year 24.95%
3Years 21.14%
5Years 36.19%
7Years 0.00%
10Years 0.00%
147 M EQUITY
-40.03%
Growth Rates
1Year -40.03%
3Years 12.17%
5Years 18.10%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition RAPT Therapeutics, Inc.
image
Current Assets 162 M
Cash & Short-Term Investments 159 M
Receivables 0
Other Current Assets 2.92 M
Non-Current Assets 11.5 M
Long-Term Investments 0
PP&E 7.68 M
Other Non-Current Assets 3.87 M
Current Liabilities 21.8 M
Accounts Payable 5.18 M
Short-Term Debt 4.9 M
Other Current Liabilities 11.8 M
Non-Current Liabilities 4.46 M
Long-Term Debt 4.46 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 47.5 38.9 24.0 24.9 77.4 63.8 47.5
Short Term Investments 111.4 210.1 165.6 86.6 0 0 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 2.9 3.6 6.6 8.2 6.2 1.3 0.7
Total Current Assets 161.8 252.7 193.0 115.6 80.5 65.1 48.2
PP&E 7.7 9.5 2.7 3.0 3.7 4.2 1.9
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0.6 0.6
Other Long Term Assets 3.9 4.0 2.9 0.4 0.4 (0.2) (0.4)
Other Assets 0 0 0 0 0 0 0
Total Assets 173.3 266.2 198.6 119.0 84.6 69.6 50.4
LIABILITIES
Accounts Payable 5.2 3.4 2.0 2.4 1.1 1.8 1.1
Short Term Debt 4.9 4.3 0 0 0 0 0
Other Current Liabilities 11.8 6.5 6.6 5.3 4.1 2.9 2.1
Total Current Liabilities 21.8 14.2 9.6 11.7 9.3 4.6 3.2
Long Term Debt 4.5 6.8 0 0 0 0 108.6
Deferred Tax Income 0 0 0 0 0 (162.1) (108.6)
Other Liabilities 0 0 2.1 2.2 2.2 1.0 0.9
Total Liabilities 26.3 21.0 12.3 14.8 11.5 5.6 112.8
EQUITY
Common Stock 3 K 3 K 3 K 2 K 2 K 2 K 1 K
Retained Earnings (484.7) (367.9) (284.0) (214.8) (161.9) (119.0) (82.8)
Other Accumulative Comprehensive Income/Loss 0.1 26 K (0.2) (0.2) 20 K 4 K (3.8)
Total Equity 147.0 245.2 186.4 104.2 73.1 64.0 (62.4)
Total Liabilities and Equity 173.3 266.2 198.6 119.0 84.6 69.6 50.4
SHARES OUTSTANDING
Common Shares Outstanding 38.3 32.5 27.4 24.1 21.8 17.3 14.5